DK2399928T3 - Specifikke TT-virus-sekvenser og kimæriske TT-virusværtscelle-DNA-molekyler til anvendelse ved diagnosticering, forebyggelse og behandling af cancer og auto-immunitet - Google Patents

Specifikke TT-virus-sekvenser og kimæriske TT-virusværtscelle-DNA-molekyler til anvendelse ved diagnosticering, forebyggelse og behandling af cancer og auto-immunitet

Info

Publication number
DK2399928T3
DK2399928T3 DK10006541.6T DK10006541T DK2399928T3 DK 2399928 T3 DK2399928 T3 DK 2399928T3 DK 10006541 T DK10006541 T DK 10006541T DK 2399928 T3 DK2399928 T3 DK 2399928T3
Authority
DK
Denmark
Prior art keywords
virus
autoimmunity
diagnosis
cancer
prevention
Prior art date
Application number
DK10006541.6T
Other languages
English (en)
Inventor
Hausen Harald Zur
Villiers Ethel-Michele De
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK2399928T3 publication Critical patent/DK2399928T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/00041Use of virus, viral particle or viral elements as a vector
    • C12N2750/00043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
DK10006541.6T 2010-06-23 2010-06-23 Specifikke TT-virus-sekvenser og kimæriske TT-virusværtscelle-DNA-molekyler til anvendelse ved diagnosticering, forebyggelse og behandling af cancer og auto-immunitet DK2399928T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10006541.6A EP2399928B1 (en) 2010-06-23 2010-06-23 Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity

Publications (1)

Publication Number Publication Date
DK2399928T3 true DK2399928T3 (da) 2018-01-29

Family

ID=43085733

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10006541.6T DK2399928T3 (da) 2010-06-23 2010-06-23 Specifikke TT-virus-sekvenser og kimæriske TT-virusværtscelle-DNA-molekyler til anvendelse ved diagnosticering, forebyggelse og behandling af cancer og auto-immunitet

Country Status (3)

Country Link
EP (1) EP2399928B1 (da)
DK (1) DK2399928T3 (da)
ES (1) ES2657705T3 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015188899A1 (en) * 2014-06-12 2015-12-17 Deutsches Krebsforschungszentrum Novel ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
AU2014280190B2 (en) * 2013-06-14 2020-04-02 Deutsches Krebsforschungszentrum TTV mirRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
US9537811B2 (en) 2014-10-02 2017-01-03 Snap Inc. Ephemeral gallery of ephemeral messages
CN114790453A (zh) * 2021-01-25 2022-07-26 上海思路迪生物医学科技有限公司 一种快速杂交捕获试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606918A (en) 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
DE69433811T2 (de) 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
DE69434447T2 (de) 1993-06-07 2006-05-18 Vical, Inc., San Diego Für die gentherapie verwendbare plasmide
CA2225460A1 (en) 1995-06-23 1997-01-09 Winston Campbell Patterson Transcriptional regulation of genes encoding vascular endothelial growth factor receptors
TNSN99210A1 (fr) * 1998-11-10 2005-11-10 Diasorin S R L Identification de genotypes du virus sen
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
PL364797A1 (en) * 1999-12-10 2004-12-13 Roche Diagnostics Gmbh Hepatitis virus sentinel virus i (svi)
DE10144346A1 (de) * 2001-09-10 2003-04-03 Deutsches Krebsforsch TT-Virus-Sequenzen in menschlichen Tumorgeweben, Mittel zu deren Nachweis sowie Tumortherapie
WO2007130519A2 (en) * 2006-05-02 2007-11-15 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Viral nucleic acid microarray and method of use
EP1992691A1 (en) * 2007-05-16 2008-11-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts New TTV sequences for diagnosis, prevention and treatment of childhood leukaemia

Also Published As

Publication number Publication date
ES2657705T3 (es) 2018-03-06
EP2399928B1 (en) 2017-11-08
EP2399928A1 (en) 2011-12-28

Similar Documents

Publication Publication Date Title
WO2014011901A3 (en) Methods and compositions for delivery of biologics
MX2016011686A (es) Composiciones utiles en el tratamiento de deficiencia de la ornitina transcarbamilasa (otc).
WO2012075040A3 (en) mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
AR079881A1 (es) Plantas tolerantes a herbicidas inhibidores de las hppd
EP3216867A4 (en) Method for modifying genome sequence to introduce specific mutation to targeted dna sequence by base-removal reaction, and molecular complex used therein
EP3115457A4 (en) Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
WO2013142324A8 (en) Neutralizing antibodies to hiv-1 and their use
WO2012094492A3 (en) Combinatorial dna taggants and methods of preparation and use thereof
WO2011106541A3 (en) Diagnostic methods involving loss of heterozygosity
EA202090994A1 (ru) Композиции и способы ингибирования экспрессии генов вируса гепатита в
MX2021000211A (es) Metodos y productos para transfeccion de celulas.
MX356625B (es) Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva.
SG10201809564YA (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
AR080353A1 (es) Plantas tolerantes a herbicidas inhibidores de las hppd
GB201020995D0 (en) Biological materials and uses thereof
MX2013007286A (es) Construccion de adn inmunomoduladora no codificante.
EP2274442A4 (en) CONSENSUS SEQUENCES OF CHIKUNGUNYA VIRUS PROTEINS, NUCLEIC ACID MOLECULES ENCODING SAME, AND COMPOSITIONS AND METHODS OF USE THEREOF
WO2012027572A3 (en) Methods for nucleic acid capture and sequencing
WO2012024396A3 (en) Compositions and methods for delivering nucleic acid molecules and treating cancer
WO2012017329A3 (en) Method for targeted genomic events in algae
WO2013110818A3 (en) Immunogens for hiv vaccination
WO2014066915A3 (en) Methods and compositions to produce ss-rnai activity with enhanced potency
WO2013124807A3 (en) Oligonucleotides for modulating gene expression and uses thereof
WO2014026110A3 (en) Compounds for improved viral transduction
WO2012037116A3 (en) Genetic variations associated with common variable immunodeficiency (cvid) and methods of use thereof